Insider · CIK 0001780980
Daniel D. Burton
Files at HCAT (Health Catalyst, Inc.). First filing Feb 27, 2024, latest Feb 27, 2024.
In brief
Daniel D. Burton files SEC Form 4 as CEO and director at HCAT (Health Catalyst, Inc.). Since Feb 27, 2024, Daniel D. Burton has reported 1 open-market buy worth $205k and 0 open-market sells worth $0, the latest filed on Feb 27, 2024.
A track record needs three past buys with six months of prices behind them; Daniel D. Burton has 0, so none is measured yet.
The newest scored trade: bought $205k of HCAT on Feb 27, 2024, filed Feb 27, 2024, scored 45 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HCAT: Health Catalyst, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | HCATbuy Health Catalyst, Inc. | $205k 26,200 shares | +2% | +24% from low-42% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 2, 2026 | HCAT Health Catalyst, Inc. | 25,795 0.04% of outstanding | $43k | Mar 2, 2026 | $212k |
| Feb 26, 2026 | HCAT Health Catalyst, Inc. | 28,875 0.04% of outstanding | $50k | Feb 26, 2026 | $162k |
| Dec 1, 2025 | HCAT Health Catalyst, Inc. | 55,715 0.08% of outstanding | $162k | Dec 1, 2025 | $28k |
| Sep 2, 2025 | HCAT Health Catalyst, Inc. | 8,335 0.01% of outstanding | $28k | Sep 2, 2025 | $31k |
| Jun 2, 2025 | HCAT Health Catalyst, Inc. | 8,658 0.01% of outstanding | $31k | Jun 2, 2025 | $154k |
| Mar 3, 2025 | HCAT Health Catalyst, Inc. | 33,677 0.05% of outstanding | $154k | Mar 3, 2025 | $278k |
| Dec 2, 2024 | HCAT Health Catalyst, Inc. | 30,987 0.05% of outstanding | $278k | Dec 2, 2024 | $30k |
| Sep 3, 2024 | HCAT Health Catalyst, Inc. | 4,174 0.01% of outstanding | $30k | Sep 3, 2024 | $29k |
| Jun 3, 2024 | HCAT Health Catalyst, Inc. | 4,442 0.01% of outstanding | $29k | Jun 3, 2024 | $40k |
| Mar 1, 2024 | HCAT Health Catalyst, Inc. | 4,973 0.01% of outstanding | $40k | Mar 1, 2024 | $63k |
| Dec 1, 2023 | HCAT Health Catalyst, Inc. | 8,478 0.01% of outstanding | $63k | Dec 1, 2023 | $84k |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -55,715 | $2.90 | $162k | 1,393,099 | Dec 3, 2025 |
| Sep 2, 2025 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -8,335 | $3.36 | $28k | 1,448,814 | Sep 4, 2025 |
| Jun 2, 2025 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -8,658 | $3.63 | $31k | 1,457,149 | Jun 3, 2025 |
| Mar 3, 2025 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -33,677 | $4.58 | $154k | 1,465,807 | Mar 4, 2025 |
| Feb 20, 2025 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +296,000 | $0.00 | $0 | 1,424,047 | Feb 24, 2025 |
| Feb 20, 2025 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +75,437 | $0.00 | $0 | 1,499,484 | Feb 24, 2025 |
| Dec 1, 2024 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -30,897 | $8.97 | $277k | 1,128,137 | Dec 3, 2024 |
| Sep 3, 2024 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -4,174 | $7.27 | $30k | 1,159,034 | Sep 5, 2024 |
| Jun 3, 2024 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -4,442 | $6.53 | $29k | 1,163,208 | Jun 4, 2024 |
| Mar 1, 2024 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -4,973 | $8.05 | $40k | 1,167,650 | Mar 5, 2024 |
| Feb 27, 2024 | HCAT Health Catalyst, Inc. | POpen-market purchase Common Stock | +26,200 | $7.81 | $205k | 1,172,623 | Feb 27, 2024 |
| Feb 20, 2024 | HCAT Health Catalyst, Inc. | AGrant or award Common Stock | +250,000 | $0.00 | $0 | 1,146,423 | Feb 22, 2024 |
| Dec 1, 2023 | HCAT Health Catalyst, Inc. | FTax withholding Common Stock | -8,478 | $7.45 | $63k | 896,423 | Dec 5, 2023 |
Questions about Daniel D. Burton
Answered from the filings on this page, as of the latest one.
Is Daniel D. Burton buying or selling?
Not in the last 12 months. Daniel D. Burton's latest open-market trade on SEC Form 4 was bought $205k of HCAT on Feb 27, 2024.
How did Daniel D. Burton's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Daniel D. Burton has 0.
Where does Daniel D. Burton file Form 4?
Daniel D. Burton has filed Form 4 at HCAT (Health Catalyst, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.